(Q56771955)

English

Different responses to interferon beta-1b treatment in patients with neuromyelitis optica and multiple sclerosis

article

In more languages

edit

Statements

instance of

scholarly article

0 references

title

Different responses to interferon beta-1b treatment in patients with neuromyelitis optica and multiple sclerosis (English)

0 references

0 references

0 references

1 reference

S. Kuwabara

5

0 references

author name string

A. Uzawa

series ordinal

1

0 references

M. Mori

series ordinal

2

0 references

S. Hayakawa

series ordinal

3

0 references

S. Masuda

series ordinal

4

0 references

publication date

21 December 2009

0 references

number of pages

5

1 reference

based on heuristic

inferred from page(s)

published in

European Journal of Neurology

0 references

volume

17

0 references

issue

5

0 references

page(s)

672-676

0 references

cites work

The spectrum of neuromyelitis optica

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02897.X

retrieved

21 January 2018

Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02897.X

retrieved

21 January 2018

Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02897.X

retrieved

21 January 2018

Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02897.X

retrieved

21 January 2018

IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02897.X

retrieved

21 January 2018

B-cell depletion with rituximab in relapsing-remitting multiple sclerosis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02897.X

retrieved

21 January 2018

Revised diagnostic criteria for neuromyelitis optica

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02897.X

retrieved

21 January 2018

Neuromyelitis optica and anti-aquaporin-4 antibodies measured by an enzyme-linked immunosorbent assay

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02897.X

retrieved

21 January 2018

Immunosuppressive therapy is more effective than interferon in neuromyelitis optica.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02897.X

retrieved

21 January 2018

A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02897.X

retrieved

21 January 2018

Identifiers

DOI

10.1111/J.1468-1331.2009.02897.X

0 references

PubMed publication ID

20039942

0 references

(Q56771955)

Different responses to interferon beta-1b treatment in patients with neuromyelitis optica and multiple sclerosis

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)